ARTICLE | Clinical News
Tetrodin: Completed Phase Ib/Ic study
June 25, 2001 7:00 AM UTC
International Wex Technologies Inc. (CDNX:WXI; WXITF), Vancouver, B.C. Product: Tetrodin Business: Neurological Therapeutic category: Ion channel modulation Target: Sodium channels Description: Sodiu...